Cours Kelyniam Global, Inc. Other OTC
Actions
KLYG
US4883591004
Equipement et technologie médicale avancés
CA 2022 | 3,02 M 2,75 M | CA 2023 | 2,67 M 2,43 M | Capitalisation | 1,83 M 1,66 M |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | 0,99 x |
Dette nette 2022 | 560 k 510 k | Dette nette 2023 | 623 k 567 k | VE / CA 2023 | 0,92 x |
PER 2022 |
-24,8
x | PER 2023 |
-8,35
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 53,55% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 09/01/18 |
Director of Finance/CFO | - | 01/02/20 | |
Chief Operating Officer | - | 01/01/11 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Operating Officer | - | 01/01/11 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 01/06/14 |
Ross Bjella
CEO | Chief Executive Officer | - | 09/01/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+9,02% | 219 Md | |
+7,41% | 183 Md | |
+11,20% | 133 Md | |
+25,41% | 108 Md | |
+0,27% | 63,06 Md | |
+12,50% | 52,02 Md | |
-0,62% | 48,2 Md | |
+0,08% | 40,37 Md | |
+13,43% | 39,35 Md |